Section 338.251. Definitions.

As used in these rules and in the interpretation and administration of sections 17401, 17412, 17432, 17433, 17435, and 17749 of the code:

(a)  "Adverse drug reaction" means  an adverse physical or  psychological reaction  which is experienced by a person resulting from diagnostic pharmaceutical agents administered by an optometrist and which occurs within 24 hours after the drug is administered. An adverse drug reaction may  be indicated by symptoms that include any of the following:

(i)   Red eye.

(ii)   Painful eye.

(iii)   Decrease in vision.

(iv)   Pale or red swelling of the periocular or periorbital tissues.

(v)   Nausea.

(vi)   Vomiting.

(vii)   Fainting.

(viii)   Mental confusion.

(ix)   essation of respiration.

(b)   "Board" means the board of optometry.

(c)   "Code" means 1978 PA 368, MCL 333.1101 et seq.

(d)  "Classroom hour" for the purpose of determining whether a course of study meets the requirements of section 17412(2)(a) or 17435(2)(b) of the code, means a 50- to 60- minute period of lecture, group discussion, or laboratory directly associated with a course in pharmacology. Time spent working in a clinic other than as part of a laboratory directly associated with a course in pharmacology does not qualify as a "classroom hour."

(e)    "Course of study in general and clinical pharmacology" means a course of study which is completed in a board-approved school or college, in general and clinical pharmacology  as  it  relates  to  optometry,   with   the characteristics described in section 17412(2)(a) of the code.  Not less than  30  of  the  60 classroom hours  of  the

course of study shall be allocated to ocular pharmacology and shall emphasize the systemic effects of, and reactions to, topical ocular diagnostic pharmaceutical agents, including the emergency management and referral of any adverse reactions that may occur.

(f)  "Course of study relating to the didactic and clinical use of therapeutic pharmaceutical agents" means a course of study which is comprised of a minimum of 10 quarter hours or 7 semester hours of credit or 100 classroom  hours   of  study,  which  is completed in a board-approved school or college, and which is in subjects relating to the didactic and clinical use of therapeutic pharmaceutical agents related to optometry.

(g)   "Department" means the Michigan department of community health.

(h)     "Emergency treatment plan for management and referral of patients  who experience an adverse drug reaction" means a plan which is submitted to the board on a board-approved form and in which the optometrist agrees to do  all of the following:

(i)   Refer patients who notify the optometrist of an adverse drug reaction to an appropriate medical specialist or facility.

(ii)     Routinely advise patients to immediately contact the optometrist if the patient experiences an adverse drug reaction.

(iii)    Place in the patient's permanent record information describing any adverse drug reaction experienced by the patient and the date and time that any patient referral was made.

History:   1944 AC; 1954 AC; 1979 AC; 1983 AACS; 1985 AACS; 1995 AACS; 2003 AACS; 2010 AACS.